Gossamer Bio GOSS
NASDAQ GOSS
$0.15 0.00 (-1.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Long-Term Deferred Tax (2018 - 2023)

Gossamer Bio (GOSS) posted quarterly Long-Term Deferred Tax of $222.2 million for Q4 2023, up 72.23% year-over-year from $129.0 million in Q4 2022, and up 72.23% quarter-over-quarter from $129.0 million in Q4 2022.

Gossamer Bio (GOSS) Long-Term Deferred Tax (2018 - 2023) Analysis & Trends

Gossamer Bio's Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $222.2 million for Q4 2023.

  • In Q4 2023, Long-Term Deferred Tax rose 72.23% year-over-year to $222.2 million; the TTM figure through Dec 2023 stood at $222.2 million (up 72.23% YoY), while the FY2023 annual figure was $222.2 million, up 72.23% from the prior year.
  • Long-Term Deferred Tax for Q4 2023 stood at $222.2 million, up from $129.0 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $222.2 million in Q4 2023, with the low at $43.6 million in Q4 2019.
  • The 4-year median for Long-Term Deferred Tax is $103.5 million (2020), against an average of $118.2 million.
  • The sharpest annual moves came in 2019 and 2023: Long-Term Deferred Tax soared 202.08% in 2019, then soared 72.23% in 2023.
  • Gossamer Bio's Long-Term Deferred Tax stood at $43.6 million in 2019, then surged by 78.67% to $77.9 million in 2020, then surged by 65.49% to $129.0 million in 2022, then jumped by 72.23% to $222.2 million in 2023.
  • Business Quant data shows GOSS's Long-Term Deferred Tax at $222.2 million in Q4 2023, $129.0 million in Q4 2022, and $77.9 million in Q4 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Gossamer Bio 49.15 Mn -7.87 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 222.16 Mn
Dec 31, 2022 128.99 Mn
Dec 31, 2020 77.95 Mn
Dec 31, 2019 43.63 Mn
Dec 31, 2018 14.44 Mn